Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical cord-derived mesenchymal stem cell therapy

Umbilical cord-derived mesenchymal stem cells · The Research-Clinical Center for Cardiac Surgery and Transplantology LLP
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Umbilical cord-derived mesenchymal stem cell therapy, covering 2017-07-18 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure [Phase 1, Phase 2]

See pricing